scispace - formally typeset
J

Jing Han

Researcher at Nanjing Medical University

Publications -  23
Citations -  769

Jing Han is an academic researcher from Nanjing Medical University. The author has contributed to research in topics: Cancer & Single-nucleotide polymorphism. The author has an hindex of 12, co-authored 21 publications receiving 654 citations.

Papers
More filters
Journal ArticleDOI

A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.

TL;DR: The five-miRNA panel in plasma may serve as a potential non-invasive biomarker in detecting the early-stage GC in patients diagnosed with gastric cancer.
Journal ArticleDOI

Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma

TL;DR: A meta‐analysis revealed that four miRNAs could be used as preclinical biomarkers for HCC screening and the expression profile of the eight‐miRNA panel can be used to discriminate HCC patients from cancer‐free controls, and the four‐mi RNA panel (alone or combined with AFP) could be a blood‐based early detection biomarker for H CC screening.
Journal ArticleDOI

Evaluation of genetic variants in microRNA biosynthesis genes and risk of breast cancer in Chinese women.

TL;DR: The findings suggested that DGCR8 rs417309 G > A might affect breast cancer risk through the interruption of miRNAs binding through the interrupts of miRNA binding.
Journal ArticleDOI

Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population.

TL;DR: In conclusion, A4 variants appear to predict higher risk of cervical cancer among HPV16-positive women, which may provide clues to the genetic basis of differences in the carcinogenicity of HPV16 variants.